[Federal Register Volume 89, Number 11 (Wednesday, January 17, 2024)]
[Notices]
[Page 2967]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-00773]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meetings

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The contract proposals and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; HHS-NIH-CDC-SBIR PHS 2024-1 Phase 
I: Novel Diagnostic Biomarker Discovery and Validation for Malaria 
and Select Neglected Tropical Diseases (NTDs) (Topic 132).
    Date: February 15, 2024.
    Time: 9:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 3G13A, 
Rockville, MD 20892 (Virtual Meeting).
    Contact Person: Mairi Noverr, Ph.D., Scientific Review Officer, 
Scientific Review Program, Division of Extramural Activities, 
National Institute of Allergy and Infectious Diseases, National 
Institutes of Health, 5601 Fishers Lane, Room 3G13A, Rockville, MD 
20852, (240) 747-7530, <a href="/cdn-cgi/l/email-protection#dcb1bdb5aeb5f2b2b3aab9aeae9cb2b5b4f2bbb3aa"><span class="__cf_email__" data-cfemail="066b676f746f2868697063747446686f6e28616970">[email protected]</span></a>.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; Small Business Innovation Research 
(SBIR) Phase II Program Contract Solicitation (PHS 2022-1) Topic 
108--Development of Rapid POC Diagnostics for Treponema pallidum 
(N01).
    Date: February 16, 2024.
    Time: 9:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 3G13A, 
Rockville, MD 20892 (Virtual Meeting).
    Contact Person: Mairi Noverr, Ph.D., Scientific Review Officer, 
Scientific Review Program, Division of Extramural Activities, 
National Institute of Allergy and Infectious Diseases, National 
Institutes of Health, 5601 Fishers Lane, Room 3G13A, Rockville, MD 
20852, (240) 747-7530, <a href="/cdn-cgi/l/email-protection#771a161e051e5919180112050537191e1f59101801"><span class="__cf_email__" data-cfemail="95f8f4fce7fcbbfbfae3f0e7e7d5fbfcfdbbf2fae3">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: January 11, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-00773 Filed 1-16-24; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>